Paul Hastings Advising Facebook on Acquisition, Leasing, and Development of New Global Headquarters

Paul, Hastings, Janofsky & Walker, a leading global law firm, announced today that the firm is advising social network service Facebook Inc. on the acquisition, leasing, and development of the company’s new global headquarters in Menlo Park, Calif. The complex deal for the one million square foot former Sun Microsystems campus involves the assignment to an investor of Facebook’s agreement to purchase the site from Oracle Corp., and the agreement of the investor to lease the entire property to Facebook following the closing.

More >>

Tags:  Paul Hastings, LLP

Simpson Thacher Represents Underwriters in Initial Public Offering by NeoPhotonics

The Firm recently represented the underwriters, led by Merrill Lynch, Pierce, Fenner & Smith Incorporated and Deutsche Bank Securities Inc. and co-managed by Piper Jaffray & Co., Morgan Keegan & Company, Inc. and ThinkEquity LLC, in connection with the underwriting of the initial public offering of common stock by NeoPhotonics Corporation (NeoPhotonics).  The offering of 8,625,000 shares, which includes the shares that were sold pursuant to the over-allotment option exercised by the underwriters, raised $94,875,000 in gross proceeds.  NeoPhotonics’ shares are listed on the New York Stock Exchange under the symbol “NPTN.”

More >>

Tags:  Simpson Thacher & Bartlett LLP

Womble Carlyle Attorneys File Amicus Curiae Brief in Landmark Global Warming Case

Today, Womble Carlyle attorneys John Sweeney, Sky Woodward and Kevin Mattingly filed an amicus curiae brief in the U.S. Supreme Court in American Electric Power Company, Inc., et al., v. State of Connecticut, et al, a landmark environmental regulation case. The brief was filed on behalf of DRI – The Voice of the Defense Bar. Sweeney serves as a National DRI Director and as Immediate Past Chair of DRI’s Climate Change Litigation Task Force.

More >>

Tags:  Womble Bond Dickinson temp

Norton Rose Advises on the Recapitalisation of Italian Food and Cosmetics Group

International legal practice Norton Rose Studio Legale has advised the Italian entrepreneur, Canio Mazzaro, on the preliminary phase of the recapitalisation of Bioera, a listed Italian food and cosmetics group currently in administration. The court of Reggio Emilia has approved Mazzaro’s offer to acquire and recapitalise Bioera, including his plan to carry out two Euro 9 million capital increases. The objective of the recapitalisation is to reinforce Bioera’s finances, restore its position as a leading company in the bio-food market and relaunch trading of Bioera shares by June 2011.

More >>

Tags:  Norton Rose Fulbright

Norton Rose Advises Sumitomo on Acquisition of 10 PV Solar Parks

International legal practice Norton Rose Studio Legale has advised Sumitomo Corporation on the acquisition of 85 percent stakes in two Italian solar power subsidiaries of German-based S.A.G. Solarstrom. As a result of an agreement signed on 3 February 2011, the Japanese-based trading conglomerate will own 10 PV solar parks located in southern Italy having total capacity generation of 9,700kw.

More >>

Tags:  Norton Rose Fulbright

Shearman & Sterling Advises on Secondary Offering and Repurchase of Quest Diagnostics’ Common Stock

Shearman & Sterling represented Quest Diagnostics Incorporated in connection with an underwritten public offering of 15,377,600 shares of Quest’s common stock held by GlaxoSmithKline plc., its largest stockholder. Concurrently with the public offering, Quest repurchased the 15,377,551 shares of its common stock from GlaxoSmithKline plc. Following this offering and the repurchase, GlaxoSmithKline plc no longer holds common stock of Quest. Deutsche Bank Securities Inc. and J.P. Morgan Securities LLC acted as joint bookrunners for the offering. Quest Diagnostics is the world’s leading provider of diagnostic testing, information and services.

More >>

Tags:  Shearman & Sterling LLP

Davis Polk – Savient Pharmaceuticals, Inc. $230 Million Convertible Senior Notes Offering

Davis Polk advised J.P. Morgan Securities LLC as the sole book-running manager and representative of the underwriters on a registered public offering by Savient Pharmaceuticals, Inc. of $230 million aggregate principal amount of its 4.75% convertible senior notes due 2018 (which included the full exercise of the over-allotment option). 

More >>

Tags:  Davis Polk & Wardwell LLP